- LevelJump Healthcare Corp. (TSXV: JUMP) sees revocation of a failure-to-file cease trade order by the Ontario Securities Commission.
- The company has refiled all necessary financial documents and is seeking approval for trading resumption on the TSX Venture Exchange.
- LevelJump maintains its focus on telehealth and radiology services despite recent regulatory challenges.
LevelJump Healthcare Corp. (TSXV: JUMP) has announced the Ontario Securities Commission's decision to revoke the failure-to-file cease trade order (FFCTO) initially imposed on May 7, 2024. The FFCTO resulted from LevelJump's lapse in filing its annual financial statements and necessary documentation for the financial year ending December 31, 2023.
To address the compliance issues, LevelJump has undertaken several corrective measures. These include refiling its management discussion and analysis (MD&A) for the 2023 financial year and interim financial statements for the periods ending March 31, 2024, and June 30, 2024. Additionally, Chief Executive Officer and Chief Financial Officer certifications have been updated and submitted alongside the refiled documents. The company's Annual Information Form has also been revised and resubmitted, along with filing the Q3 2024 financials.
The company remains committed to re-engaging with its shareholders by holding a meeting within three months post-revocation of the FFCTO. Concurrently, LevelJump is preparing an application to the TSX Venture Exchange (TSXV) to resume trading, which is currently suspended. The company has assured that its core mission of providing telehealth solutions and in-person radiology services through its diagnostic centres stays unchanged.
LevelJump's business operations concentrate on offering teleradiology services to hospitals and imaging centers, along with in-person radiology support, primarily for critical and emergency care patients. The firm has emphasized that the nature of its business has remained consistent throughout the regulatory review period.
